Henry Schein Inc. says it plans to acquire a 60% stake in dental implant maker BioHorizons for an undisclosed amount.
The deal calls for Schein to lend BioHorizons about $145 million to fund a distribution to shareholders, followed by an equity investment. BioHorizons would continue to operate as an independent company, according to a regulatory filing. Other details of the agreement, expected to close by the end of the year, were not disclosed.
Birmingham, Ala.-based BioHorizons makes dental implants and employs about 325 workers, according to the filing, and posts annual revenues of roughly $115 million.